Piper Jaffray Downgrades Sequenom Stock
September 24, 2012
Piper Jaffray Downgrades Sequenom Stock
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- MaterniT21 Doubles Sequenom's Revenues; Firm Inks Deal with Blue Cross Blue Shield Association
May 15, 2013 / Clinical Sequencing News - Credit Suisse Upgrades Sequenom to Neutral
May 13, 2013 / GenomeWeb Daily News - Experts Weigh in on Ethical Considerations for NIPT at Biology of Genomes Panel
May 10, 2013 / GenomeWeb Daily News - Sequenom's Q1 Revenues More than Double
May 10, 2013 / GenomeWeb Daily News - NIPT Developers Consider Sub-Chromosomal Alterations
May 1, 2013 / Clinical Sequencing News